0001127602-13-017250.txt : 20130517 0001127602-13-017250.hdr.sgml : 20130517 20130517121230 ACCESSION NUMBER: 0001127602-13-017250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130515 FILED AS OF DATE: 20130517 DATE AS OF CHANGE: 20130517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 13853928 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 2696738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-05-15 0000820096 PERRIGO CO PRGO 0001242215 PAPA JOSEPH C C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN MI 49010 1 1 1 President and CEO Chairman Common Stock 2013-05-15 4 M 0 5000 35.85 A 105000 D Common Stock 2013-05-15 4 S 0 3800 120.3596 D 101200 D Common Stock 2013-05-15 4 S 0 1200 121.0005 D 100000 D Employee Stock Option Right to Buy 35.85 2013-05-15 4 M 0 5000 0 D 2018-08-25 Common Stock 5000 53963 D This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 8, 2012. This 10b5-1 sales plan will expire on the close of business November 8, 2013. The price in column 4 is a weighted average. The prices actually received ranged from $119.86 to $120.86. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $120.93 to $121.11. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Exercisable in 3 equal annual installments beginning 8/25/09. /s/ Joseph C. Papa 2013-05-16